BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 852498)

  • 1. First pass hydroxylation of nortriptyline: concentrations of parent drug and major metabolites in plasma.
    Alván G; Borga O; Lind M; Palmér L; Siwers B
    Eur J Clin Pharmacol; 1977 Mar; 11(3):219-24. PubMed ID: 852498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of simultaneous treatment with low doses of perphenazine on plasma and urine concentrations of nortriptyline and 10-hydroxynortriptyline.
    Kragh-Sorensen P; Borgå O; Garle M; Bolvig Hansen L; Hansen CE; Hvidberg EF; Larsen NE; Sjöqvist F
    Eur J Clin Pharmacol; 1977 Jul; 11(6):479-83. PubMed ID: 891595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nortriptyline metabolism in chronic renal failure: metabolite elimination.
    Dawling S; Lynn K; Rosser R; Braithwaite R
    Clin Pharmacol Ther; 1982 Sep; 32(3):322-9. PubMed ID: 7105623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of observed and predicted bioavailability of nortriptyline in humans following oral administration.
    Gibaldi M
    J Pharm Sci; 1975 Jun; 64(6):1036-7. PubMed ID: 1133723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-pass metabolism of nortriptyline in man.
    Gram LF; Overo KF
    Clin Pharmacol Ther; 1975 Sep; 18(3):305-14. PubMed ID: 1164819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No circadian effect on nortriptyline kinetics in man.
    Nakano S; Hollister LE
    Clin Pharmacol Ther; 1978 Feb; 23(2):199-203. PubMed ID: 620481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for the determination of amitriptyline and its metabolites nortriptyline, 10-hydroxyamitriptyline, and 10-hydroxynortriptyline in human plasma using stable isotope dilution and gas chromatography-chemical ionization mass spectrometry (GC-CIMS).
    Garland WA; Muccino RR; Min BH; Cupano J; Fann WE
    Clin Pharmacol Ther; 1979 Jun; 25(6):844-56. PubMed ID: 376209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of amitriptyline and one of its metabolites, nortriptyline, in rats: little contribution of considerable hepatic first-pass effect to low bioavailability of amitriptyline due to great intestinal first-pass effect.
    Bae SK; Yang KH; Aryal DK; Kim YG; Lee MG
    J Pharm Sci; 2009 Apr; 98(4):1587-601. PubMed ID: 18780336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nortriptyline formation after single oral and intramuscular doses of amitriptyline.
    Mellström B; Alván G; Bertilsson L; Potter WZ; Säwe J; Sjöqvist F
    Clin Pharmacol Ther; 1982 Nov; 32(5):664-7. PubMed ID: 7128008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The demethylation of amitriptyline administered by oral and intramuscular routes.
    Burch JE; Herries DG
    Psychopharmacology (Berl); 1983; 80(3):249-53. PubMed ID: 6412269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of intravenous and oral amitriptyline and its active metabolite nortriptyline in Greyhound dogs.
    Norkus C; Rankin D; KuKanich B
    Vet Anaesth Analg; 2015 Nov; 42(6):580-9. PubMed ID: 25683584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cimetidine interaction with imipramine and nortriptyline.
    Henauer SA; Hollister LE
    Clin Pharmacol Ther; 1984 Feb; 35(2):183-7. PubMed ID: 6692646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline in human liver microsomes.
    Mellström B; von Bahr C
    Drug Metab Dispos; 1981; 9(6):565-8. PubMed ID: 6120818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteers.
    Dawling S; Crome P; Braithwaite R
    Clin Pharmacokinet; 1980; 5(4):394-401. PubMed ID: 6994983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of observed and predicted first-pass metabolism of nortriptyline in humans.
    Niazi S
    J Pharm Sci; 1976 Oct; 65(10):1535-6. PubMed ID: 978417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast and sensitive LC-MS/MS assay for quantification of nortriptyline and its active metabolites E- and Z-10-hydroxynortriptyline in human plasma.
    Bonke G; Jensen BP
    Bioanalysis; 2010 Sep; 2(9):1553-60. PubMed ID: 21083284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic aspects on once-daily nortriptyline administration.
    Overø KF
    Neuropsychobiology; 1980; 6(1):34-41. PubMed ID: 7366812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.
    Mellström B; Bertilsson L; Säwe J; Schulz HU; Sjöqvist F
    Clin Pharmacol Ther; 1981 Aug; 30(2):189-93. PubMed ID: 7249504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects.
    Woolhouse NM; Adjepon-Yamoah KK; Mellström B; Hedman A; Bertilsson L; Sjöqvist F
    Clin Pharmacol Ther; 1984 Sep; 36(3):374-8. PubMed ID: 6467797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of perphenazine with the kinetics of nortriptyline.
    Overo KF; Gram LF; Hansen V
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40(1):97-105. PubMed ID: 576367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.